Ataxia-pancytopenia syndrome

Ataxia-pancytopenia syndrome is a rare, genetic, neurological disorder characterized by early-onset cerebellar ataxia, associated with hematological abnormalities, including pancytopenia and myelodysplastic syndrome, and a predisposition to developing myeloid leukemia.

Symptoms[edit | edit source]

The symptoms of Ataxia-pancytopenia syndrome include:

Cerebellar ataxia
Pancytopenia
Myelodysplastic syndrome
Predisposition to developing myeloid leukemia

Causes[edit | edit source]

Ataxia-pancytopenia syndrome is caused by mutations in the SAMD9L gene. This gene provides instructions for making a protein that is involved in controlling cell growth and division.

Diagnosis[edit | edit source]

Diagnosis of Ataxia-pancytopenia syndrome is based on the presence of characteristic signs and symptoms. Genetic testing can confirm the diagnosis.

Treatment[edit | edit source]

Treatment of Ataxia-pancytopenia syndrome is focused on managing the symptoms. This may include physical therapy for ataxia and treatment for hematological abnormalities.

Prognosis[edit | edit source]

The prognosis for individuals with Ataxia-pancytopenia syndrome varies. Some individuals may have a normal lifespan, while others may have a shortened lifespan due to complications of the disorder.

See also[edit | edit source]

Ataxia-pancytopenia syndrome Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.